StonvexLoading…
StonvexStonvexStonvexCore line items from IESC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.85B | $870.96M | $3.37B | $2.47B |
Operating Income | $209.99M | $97.73M | $383.53M | $279.22M |
Net Income | $202.08M | $91.77M | $305.98M | $209.56M |
EPS (Diluted) | $9.95 | $4.51 | $15.02 | $10.03 |
Total Assets | $1.99B | $1.66B | $1.60B | $1.47B |
Total Liabilities | $916.79M | $693.17M | $707.70M | $647.30M |
Cash & Equivalents | $48.66M | $88.83M | $127.17M | $101.44M |
Free Cash Flow OCF − CapEx | $52.58M | $-18.87M | $218.84M | $106.83M |
Shares Outstanding | 19.92M | 19.93M | 19.85M | 19.85M |